DENOSUMAB IN MEN: 6 YEARS RETROSPECTIVE, REALWORLD CLINICAL PRACTICE SINGLE CENTRE STUDY (OSTEOPROM) - OSTEOPOROSIS TREATMENT, FRACTURES AND SAFETY DATA

被引:0
|
作者
Poksane, M. R. S. [1 ]
Rasa, D. R. [2 ]
机构
[1] Riga Stradins Univ, Riga, Latvia
[2] Riga East Clin Univ Hosp, Riga, Latvia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P110
引用
收藏
页码:S35 / S35
页数:1
相关论文
共 50 条
  • [1] DENOSUMAB IN MEN: 6 YEARS RETROSPECTIVE, REAL-WORLD CLINICAL PRACTICE SINGLE CENTRE STUDY (OSTEOPROM). OSTEOPOROSIS TREATMENT AND FRACTURES DATA - PART 1
    Poksane, D.
    Rasa, I.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S292 - S292
  • [2] TREATMENT AND MANAGEMENT OF OSTEOPOROTIC FRACTURES IN MEN: A 8-YEAR STUDY OF REAL-WORLD CLINICAL PRACTICE IN A SINGLE-CENTRE (OSTEOPROM, PART III)
    Poksane, D.
    Rasa, I.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S224 - S225
  • [3] OSTEOPROM PART II: TREATMENT AND MANAGEMENT OF OSTEOPOROTIC FRACTURES IN MEN-A 7-YEAR STUDY OF REAL-WORLD CLINICAL PRACTICE IN A SINGLE-CENTRE
    Poksane, D.
    Rasa, I.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S163 - S163
  • [4] Denosumab and clinical outcomes among men with osteoporosis: a retrospective cohort study
    Huang, Zhenna
    Liao, Tzu-Chi
    Chuang, Albert Tzu-Ming
    Shao, Shih-Chieh
    Lange, Jeff
    Lin, Tzu-Chieh
    Kim, Min
    Lai, Edward Chia-Cheng
    OSTEOPOROSIS INTERNATIONAL, 2025, 36 (03) : 465 - 473
  • [5] EFFECTS OF TERIPARATIDE OR DENOSUMAB IN ELDERLY WOMEN WITH SEVERE OSTEOPOROSIS AND HIP FRACTURES: A 2-YEAR RETROSPECTIVE, SINGLE CENTRE, OBSERVATIONAL STUDY
    Coppola, C.
    Agnusdei, D.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S199 - S199
  • [6] Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
    Masaki Kobayashi
    Kenjiro Sawada
    Akihiko Yoshimura
    Misa Yamamoto
    Aasa Shimizu
    Kotaro Shimura
    Naoko Komura
    Mayuko Miyamoto
    Kyoso Ishida
    Tadashi Kimura
    BMC Women's Health, 20
  • [7] Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
    Kobayashi, Masaki
    Sawada, Kenjiro
    Yoshimura, Akihiko
    Yamamoto, Misa
    Shimizu, Aasa
    Shimura, Kotaro
    Komura, Naoko
    Miyamoto, Mayuko
    Ishida, Kyoso
    Kimura, Tadashi
    BMC WOMENS HEALTH, 2020, 20 (01)
  • [8] Risk factors for nonresponse to 2 years of denosumab administration in patients with osteoporosis: A retrospective single-center cohorts study
    Yamamoto, Akiko
    Nagao, Masashi
    Nishizaki, Yuji
    Maeda, Eri
    Ishijima, Muneaki
    HEALTH SCIENCE REPORTS, 2024, 7 (04)
  • [9] Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures
    Jun Iwamoto
    Mitsuyoshi Uzawa
    Clinical Rheumatology, 2016, 35 : 205 - 212
  • [10] Efficacy and Safety of Romosozumab Treatment in Male and Female Patients with Osteoporosis. A Retrospective Cohort Study at a Single Clinical Center
    Abreu Lomba, Alin
    Vernaza Trujillo, David Alexander
    Molina Restrepo, Jose Fernando
    Acosta Tascon, Lizeth
    Osorio Escorcia, Paola Milena
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 159 - 159